Eduardo López

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Scott A. Halperin, Lingyun Ye, Donna MacKinnon‐Cameron et al. · The Lancet · 2021 · 237 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Hemolytic Uremic Syndrome and Diarrhea in Argentine Children: The Role of Shiga-like Toxins

Eduardo López, S Grinstein, Susana Devoto et al. · The Journal of Infectious Diseases · 1989 · 172 citations

Life Sciences, Microbiology, Pediatrics +17

Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome

Michael J. Brian, M Frosolono, Barbara E. Murray et al. · Journal of Clinical Microbiology · 1992 · 136 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Multinational study of pneumococcal serotypes causing acute otitis media in children

William P. Hausdorff, Greg Yothers, Ron Dagan et al. · The Pediatric Infectious Disease Journal · 2002 · 120 citations

Medicine, Microbiology, Pediatrics +17

Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing <i>Escherichia coli</i>

Eduardo López, María M Contrini, Eduardo Glatstein et al. · Antimicrobial Agents and Chemotherapy · 2009 · 103 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +11